The APOE gene variants ε2, ε3, and ε4 are well-studied. ε4 is the strongest known genetic risk factor for Alzheimer's disease, especially in women. Studies indicate that women carrying ε4 have a higher risk than men with the same genotype. However, the effect is not deterministic—many ε4 carriers never develop the disease. Additionally, hormonal factors (e.g., menopause, hormone therapy) may modulate risk. The evidence for the APOE ε4–Alzheimer link is human-strong (numerous GWAS and longitudinal studies). For sex-specific interactions, the evidence is moderate. Importantly, a genetic test alone cannot diagnose disease. If there is a family history or symptoms, medical consultation is essential. MyBody-X tests are lifestyle analyses, not medical diagnostics. Their utility is limited to risk indication.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-3428c5c65f531e773bc75b23